Skip to main content
Premium Trial:

Request an Annual Quote

NuGen to Open Two New Facilities

NEW YORK (GenomeWeb News) – NuGen Technologies plans to open two new facilities in November. The plans include a move from an existing facility in San Carlos, Calif., into a larger one, and a new research facility in Seattle.

The genomic sample prep company said today that the new facilities are part of its plan to expand its technology portfolio "to include breakthrough applications in the [next-generation sequencing] market." NuGen said its products will offer researchers "the ability to convert a broader range of material types into sequencing libraries while streamlining sample preparation workflow."

One of its new products will be a sample prep kit for next-generation RNA-Seq, with other products for the next-gen sequencing market planned for the near future.

"Our commercial success to date allows us to make a significant investment in establishing a strong presence in the high-growth NGS market," Elizabeth Hutt, NuGen's CEO, said in a statement. "Part of that investment is the recruitment of a team of new scientists, led by Dr. Christopher Raymond, formerly of Rosetta Inpharmatics."

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.